Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 186 (CCDC186) is a protein encoded by the CCDC186 gene on human chromosome 10q25.3[2][4]. This protein is primarily involved in the biogenesis and maturation of dense-core vesicles (DCVs), which are crucial for neuromodulator and hormone release in neurons and endocrine cells[1][3][7]. CCDC186 acts as a Rab2-interacting protein, participates in the trafficking and cargo sorting of secretory vesicles, and colocalizes with endosomal and recycling machinery[1][3][4]. Disruption or mutation of CCDC186 can impair vesicular trafficking, resulting in defective secretion of regulatory molecules, which may be relevant in both neurodevelopmental and endocrine pathology[1][7]. The gene is ubiquitously expressed with higher expression in some cancers (notably breast, bladder, and prostate), and has been implicated as a fusion partner in rare cancers[2][3]. CCDC186 is not a classical therapeutic target (not a receptor, enzyme, or transporter), nor are approved drugs known to target it directly[6][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 186 (CCDC186).